Choosing Between In-House and Outsourced GxP Compliance Support: Which Approach Fits Your Organization?
Key takeaways Growing study complexity and competing priorities can stretch a quality team before leaders know whether to hire or
Key takeaways Growing study complexity and competing priorities can stretch a quality team before leaders know whether to hire or
Advarra’s position on AI in IRB review: what the board will always decide, where AI can fit in IRB operations,
A site wants to take on a study and projects strong enrollment. Before that projection becomes part of the recruitment
Study startup depends on coordinated work across sponsors, contract research organizations (CROs), sites, review bodies, and technology systems. Documents must
Adaptive study designs are best suited for oncology clinical trials when meaningful uncertainty exists and a protocol can prospectively use
As AI becomes part of research workflows, the people responsible for ethical oversight need opportunities to examine its implications together
Clinical trial audits are independent quality assurance evaluations of trial activities, records, systems, facilities, and organizations. The main types include:
Christy Frey has spent nearly two decades helping research move forward—ethically, efficiently, and always with people in mind. As senior
Investigator-initiated trials (IITs) play a critical role in advancing clinical research by allowing investigators to pursue important scientific questions beyond
The U.S. Office of Information and Regulatory Affairs (OIRA), within the Office of Management and Budget (OMB), released the federal
Planned changes outlined in the U.S. federal government’s 2026 Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory
On July 3, 2026, the U.S. Office of Information and Regulatory Affairs (OIRA), within the Office of Management and Budget